scholarly journals Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

EP Europace ◽  
2011 ◽  
Vol 14 (1) ◽  
pp. 8-27 ◽  
Author(s):  
P. Kirchhof ◽  
G. Y. H. Lip ◽  
I. C. Van Gelder ◽  
J. Bax ◽  
E. Hylek ◽  
...  
2011 ◽  
Vol 106 (12) ◽  
pp. 1012-1019. ◽  
Author(s):  
Gregory Lip ◽  
Isabelle Van Gelder ◽  
Jeroen Bax ◽  
Elaine Hylek ◽  
Stefan Kääb ◽  
...  

SummaryThere are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.


EP Europace ◽  
2015 ◽  
Vol 18 (1) ◽  
pp. 37-50 ◽  
Author(s):  
Paulus Kirchhof ◽  
Günter Breithardt ◽  
Jeroen Bax ◽  
Gerlinde Benninger ◽  
Carina Blomstrom-Lundqvist ◽  
...  

2020 ◽  
Vol 68 (8) ◽  
pp. 1317-1333
Author(s):  
Malini Riddle ◽  
Richard McCallum ◽  
Chandra Prakash Ojha ◽  
Timir Kumar Paul ◽  
Vineet Gupta ◽  
...  

Atrial fibrillation (AFIB) is the most common heart rhythm abnormality and is associated with significant morbidity and mortality. While the treatment of AFIB involves strategies of rate with or without rhythm control, it is also essential to strategize appropriate therapies to prevent thromboembolic complications arising from AFIB. Previously, anticoagulation was the main treatment option which exposed patients to higher than usual risk of bleeding. However, with the advent of new technology, novel therapeutic options aimed at surgical or percutaneous exclusion or occlusion of the left atrial appendage in preventing thromboembolic complications from AFIB have evolved. This review evaluates recent advances and therapeutic options in treating AFIB with a special focus on both surgical and percutaneous interventions which can reduce and/or eliminate thromboembolic complications of AFIB.


Sign in / Sign up

Export Citation Format

Share Document